Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytogenetic and proliferative potentials in meningiomas.

M Debiec-Rychter1, W Biernat, J Limon

  • 1Laboratory of Tumor Biology, University Medical School, Lódź.

Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists
|March 18, 2000
PubMed
Summary

The extent of chromosomal abnormalities in meningiomas does not directly correlate with tumor growth potential. While more chromosomal changes are linked to higher tumor grades, Ki-67 staining index showed no significant difference based on karyotype complexity in benign tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2019
Same author

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Influence of Cytochrome P450, ABC and SLC Gene Polymorphisms on Imatinib Therapy Outcome of Patients with Gastrointestinal Stromal Tumours (GIST).

Folia biologica·2017
Same author

Phalangeal chondrosarcoma: A rare presentation with an unusual biological behavior.

Hand surgery & rehabilitation·2017

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • Meningiomas are tumors arising from the meninges.
  • Understanding the relationship between genetic alterations and tumor behavior is crucial for prognosis.

Purpose of the Study:

  • To investigate the correlation between chromosomal abnormalities and proliferative potential (Ki-67 staining index) in meningiomas.
  • To assess if the complexity of genomic changes relates to tumor grade and histological subtype.

Main Methods:

  • Cytogenetic analysis was performed on 51 meningioma samples.
  • Ki-67 staining index was used to measure tumor proliferation.
  • Tumors were classified by histological subtype and WHO grade.

Main Results:

Related Experiment Videos

  • No significant difference in chromosomal changes was observed among histological subtypes.
  • A significant association was found between the number of chromosomal abnormalities and tumor grade (benign, atypical, malignant).
  • Benign meningiomas had lower mean Ki-67 SI (1.6%) compared to atypical (7.4%) and malignant (14.7%) tumors, but Ki-67 SI did not significantly differ based on karyotype complexity within benign tumors.

Conclusions:

  • The degree of genomic abnormalities at the chromosomal level in meningiomas does not directly predict their proliferative potential.
  • Tumor grade is associated with chromosomal complexity, but not necessarily with the growth rate as indicated by Ki-67.